Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Afreen Usmani, Anuradha Mishra & Mohd Ahmad. (2018) Nanomedicines: a theranostic approach for hepatocellular carcinoma. Artificial Cells, Nanomedicine, and Biotechnology 46:4, pages 680-690.
Read now
Read now
Articles from other publishers (34)
Jia-Peng Lin, Mao-Hua Huang, Zhi-Ting Sun, Lei Chen, Yu-He Lei, Yu-Qing Huang, Ming Qi, Shu-Ran Fan, Shou-Guo Chen, Chi-Wing Chung, Mei-Ching Chan, Jun-Shan Liu, Min Hu, Min-Feng Chen, Wen-Cai Ye, Yue-Yue Chen & Li-Juan Deng. (2023) Periplocin inhibits hepatocellular carcinoma progression and reduces the recruitment of MDSCs through AKT/NF-κB pathway. Life Sciences 324, pages 121715.
Crossref
Crossref
Kavin Sugumar, Sarah C. Markt, Jonathan J. Hue, Richard S. Hoehn, Richard T. Lee, Kenneth D. Chavin, Luke D. Rothermel, Jordan M. Winter, Jeffrey M. Hardacre, John B. Ammori & Lee M. Ocuin. (2022) Black race is independently associated with underutilization of transplantation for clinical T1 hepatocellular carcinoma. HPB 24:6, pages 925-932.
Crossref
Crossref
Hong-Gang Qian, Qiong Wu, Jian-Hui Wu, Xiu-Yun Tian, Wei Xu & Chun-Yi Hao. (2022) Long non‑coding RNA LINC00238 suppresses the malignant phenotype of liver cancer by sponging miR‑522. Molecular Medicine Reports 25:2.
Crossref
Crossref
S Ye, B Wang, Y Zhou, Q Sun & X Yang. (2022) Sortilin 1 regulates hepatocellular carcinoma progression by activating the PI3K/AKT signaling. Human & Experimental Toxicology 41, pages 096032712211401.
Crossref
Crossref
Xili Ding, Yuqi He & Xiaoming Li. 2021. Decellularized Materials. Decellularized Materials
415
487
.
Saleh A. Alanazi, Fars Alanazi, Nazrul Haq, Faiyaz Shakeel, Mohamed M. Badran & Gamaleldin I. Harisa. (2020) Lipoproteins-Nanocarriers as a Promising Approach for Targeting Liver Cancer: Present Status and Application Prospects. Current Drug Delivery 17:10, pages 826-844.
Crossref
Crossref
Zhulin Wu, Li He, Lianan Wang & Lisheng Peng. (2020) Systematically Exploring the Antitumor Mechanisms of Core Chinese Herbs on Hepatocellular Carcinoma: A Computational Study. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-13.
Crossref
Crossref
Teng Yong-Jiea, Liu Zhuob, Liao Liuc, Chen Yuanc, Huang Xiao-Did & Tian Xue-Feic. (2020) STAT3 Inhibition by Centipede Scolopendra Extract in Liver Cancer HepG2 Cells and Orthotopic Mouse Models of Hepatocellular Carcinoma. Digital Chinese Medicine 3:2, pages 67-79.
Crossref
Crossref
Feng Xue, Lixue Yang, Binghua Dai, Hui Xue, Lei Zhang, Ruiliang Ge & Yanfu Sun. (2020) Bioinformatics profiling identifies seven immune-related risk signatures for hepatocellular carcinoma. PeerJ 8, pages e8301.
Crossref
Crossref
Zhang, Lin, Chan, Liu, Lu, Lin, Hu, Shi, Zhang & Yang. (2019) Dual-functional Liposomes with Carbonic Anhydrase IX Antibody and BR2 Peptide Modification Effectively Improve Intracellular Delivery of Cantharidin to Treat Orthotopic Hepatocellular Carcinoma Mice. Molecules 24:18, pages 3332.
Crossref
Crossref
Liat Gutin, Francis Yao, Jennifer L. Dodge, Joshua Grab & Neil Mehta. (2019) Comparison of Liver Transplant Wait-List Outcomes Among Patients With Hepatocellular Carcinoma With Public vs Private Medical Insurance. JAMA Network Open 2:8, pages e1910326.
Crossref
Crossref
Jun-Shan Liu, Chu-Ying Huo, Hui-Hui Cao, Chun-Lin Fan, Jian-Yang Hu, Li-Juan Deng, Zi-Bin Lu, Hua-Yi Yang, Lin-Zhong Yu, Zhi-Xian Mo & Zhi-Ling Yu. (2019) Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway. Phytomedicine 61, pages 152843.
Crossref
Crossref
Huai Wang, Peng Liao, Shelya X Zeng & Hua Lu. (2019) It takes a team: a gain-of-function story of p53-R249S. Journal of Molecular Cell Biology 11:4, pages 277-283.
Crossref
Crossref
Guo-jie Qiao, Liang Chen, Jin-cai Wu & Zhou-ri Li. (2019) Identification of an eight-gene signature for survival prediction for patients with hepatocellular carcinoma based on integrated bioinformatics analysis. PeerJ 7, pages e6548.
Crossref
Crossref
Ahmed H.E. Hassan, Hye Rim Park, Yoon Mi Yoon, Hye In Kim, Sung Yeun Yoo, Kun Won Lee & Yong Sup Lee. (2019) Antiproliferative 3-deoxysphingomyelin analogs: Design, synthesis, biological evaluation and molecular docking of pyrrolidine-based 3-deoxysphingomyelin analogs as anticancer agents. Bioorganic Chemistry 84, pages 444-455.
Crossref
Crossref
Md. Maqusood Alam, Ahmed H.E. Hassan, Kun Won Lee, Min Chang Cho, Ji Seul Yang, Jiho Song, Kyung Hoon Min, Jongki Hong, Dong-Hyun Kim & Yong Sup Lee. (2019) Design, synthesis and cytotoxicity of chimeric erlotinib-alkylphospholipid hybrids. Bioorganic Chemistry 84, pages 51-62.
Crossref
Crossref
Daisuke Kawaguchi, Yukihiko Hiroshima, Takafumi Kumamoto, Ryutaro Mori, Ryusei Matsuyama, Yasushi Ichikawa, Yoshiaki Inayama & Itaru Endo. (2019) Effect of Portal Vein Ligation Plus Venous Congestion on Liver Regeneration in Rats. Annals of Hepatology 18:1, pages 89-100.
Crossref
Crossref
Ning Bai, Eming Peng, Xingsheng Qiu, Ning Lyu, Zhejia Zhang, Yiming Tao, Xinying Li & Zhiming Wang. (2018) circFBLIM1 act as a ceRNA to promote hepatocellular cancer progression by sponging miR-346. Journal of Experimental & Clinical Cancer Research 37:1.
Crossref
Crossref
Juan Li, Yuting He, Yuan Cao, Yan Yu, Xiaolong Chen, Xiaojuan Gao & Qiuyue Hu. (2018) Upregulation of Twist is involved in Gli1 induced migration and invasion of hepatocarcinoma cells. Biological Chemistry 399:8, pages 911-919.
Crossref
Crossref
Qiuju Han, Yaqun Wang, Min Pang & Jian Zhang. (2017) STAT3-blocked whole-cell hepatoma vaccine induces cellular and humoral immune response against HCC. Journal of Experimental & Clinical Cancer Research 36:1.
Crossref
Crossref
Richard S. Hoehn, Dennis J. Hanseman, Vikrom K. Dhar, Derek E. Go, Michael J. Edwards & Shimul A. Shah. (2017) Opportunities to Improve Care of Hepatocellular Carcinoma in Vulnerable Patient Populations. Journal of the American College of Surgeons 224:4, pages 697-704.
Crossref
Crossref
Jun Pan, Sheng Yan, Jun-jie Gao, Ying-ying Wang, Zhong-jie Lu, Chen-wei Cui, Yao-hui Zhang, Yan Wang, Xue-qin Meng, Lin Zhou, Hai-yang Xie, Jessica Zheng, Ming H Zheng & Shu-sen Zheng. (2016) In-vivo organ engineering: Perfusion of hepatocytes in a single liver lobe scaffold of living rats. The International Journal of Biochemistry & Cell Biology 80, pages 124-131.
Crossref
Crossref
M. Simonelli, P. Zucali, A. Santoro, M.B. Thomas, F.G. de Braud, H. Borghaei, J. Berlin, C.S. Denlinger, C. Noberasco, L. Rimassa, T.-Y. Kim, P.A. English, A. Abbattista, C. Gallo Stampino, M. Carpentieri & J.A. Williams. (2016) Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinoma. Annals of Oncology 27:9, pages 1782-1787.
Crossref
Crossref
Xuyu Yang, Xiaoling Zhou, Paul Tone, Marian E. Durkin & Nicholas C. Popescu. (2016) Cooperative antiproliferative effect of coordinated ectopic expression of DLC1 tumor suppressor protein and silencing of MYC oncogene expression in liver cancer cells: Therapeutic implications. Oncology Letters 12:2, pages 1591-1596.
Crossref
Crossref
Myoung Sook Han, Tamera Barrett, Michael A. Brehm & Roger J. Davis. (2016) Inflammation Mediated by JNK in Myeloid Cells Promotes the Development of Hepatitis and Hepatocellular Carcinoma. Cell Reports 15:1, pages 19-26.
Crossref
Crossref
Lin Chen, Haitao Guan, Chunyan Gu, Yali Cao, Jianguo Shao & Feng Wang. (2015) miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL. Tumor Biology 37:2, pages 2497-2507.
Crossref
Crossref
Z. M. Younossi, M. Stepanova, S. Saab, A. Ahmed, B. Lam, M. Srishord, C. Venkatesan, H. Wai & L. Henry. (2015) The impact of viral hepatitis‐related hepatocellular carcinoma to post‐transplant outcomes. Journal of Viral Hepatitis 23:1, pages 53-61.
Crossref
Crossref
Rheal A. Towner & Robert A. Floyd. 2016. Redox-Active Therapeutics. Redox-Active Therapeutics
245
264
.
Huawen Shi, Guangchao Yang, Tongsen Zheng, Jiabei Wang, Lulu Li, Yingjian Liang, Changming Xie, Dalong Yin, Boshi Sun, Jing Sun, Huanlai Wang, Shangha Pan, Hongchi Jiang, WanYee Lau & Lianxin Liu. (2015) A preliminary study of ALPPS procedure in a rat model. Scientific Reports 5:1.
Crossref
Crossref
Christine S. M. Lau, Krishnaraj Mahendraraj & Ronald S. Chamberlain. (2015) Hepatocellular Carcinoma in the Pediatric Population: A Population Based Clinical Outcomes Study Involving 257 Patients from the Surveillance, Epidemiology, and End Result (SEER) Database (1973–2011). HPB Surgery 2015, pages 1-10.
Crossref
Crossref
Richard S. Hoehn, Dennis J. Hanseman, Koffi Wima, Audrey E. Ertel, Ian M. Paquette, Daniel E. Abbott & Shimul A. Shah. (2015) Does race affect management and survival in hepatocellular carcinoma in the United States?. Surgery 158:5, pages 1244-1251.
Crossref
Crossref
Richard S. Hoehn, Dennis J. Hanseman, Peter L. Jernigan, Koffi Wima, Audrey E. Ertel, Daniel E. Abbott & Shimul A. Shah. (2015) Disparities in care for patients with curable hepatocellular carcinoma. HPB 17:9, pages 747-752.
Crossref
Crossref
BING GAO, SHUFANG NING, JILIN LI, HAIZHOU LIU, WENE WEI, FEIXIANG WU, YANPING TANG, YAN FENG, KEZHI LI & LITU ZHANG. (2015) Integrated analysis of differentially expressed mRNAs and miRNAs between hepatocellular carcinoma and their matched adjacent normal liver tissues. Oncology Reports 34:1, pages 325-333.
Crossref
Crossref
Chongyi Li, Yanli Xiong, Zhaoyang Zhong, Shiheng Zhang, Yu Peng, Lin’ang Wang, Nan Dai, Mengxia Li, Tao Ren, Lixia Gan & Dong Wang. (2014) Association Between a Variant in ADAMTS5 and the Susceptibility to Hepatocellular Carcinoma in a Chinese Han Population. Cell Biochemistry and Biophysics 72:1, pages 221-225.
Crossref
Crossref